Thanks Triple9. No question efficacy is far more important. Safety is pretty much a given. It's doubly outstanding that we have these results coming from Sheba Hospital and backed by the Israeli government. IMO none of this is factored into the pps right now. We will have a product on the market backed by scientific research in several countries worldwide. Market for psoriasis cream is easily $1 Billion/year... possibly 3 or 4 times that.